{"id":"W3044947482","doi":"10.1053/j.ajkd.2020.05.014","title":"We Can Finally Stop Worrying About SGLT2 Inhibitors and Acute Kidney Injury","year":2020,"lang":"en","type":"letter","venue":"American Journal of Kidney Diseases","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto General Hospital; Diabetes Canada; University of Toronto","funders":"","keywords":"Medicine; Canagliflozin; Empagliflozin; Albuminuria; Renal function; Diabetic nephropathy; Kidney disease; Acute kidney injury; Diabetes mellitus; Internal medicine; Type 2 diabetes; Nephropathy; Kidney; Type 2 Diabetes Mellitus; Creatinine; Linagliptin; Urology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001802141,0.0009229867,0.001438507,0.0009420795,0.006164342,0.004656018,0.001109018,0.0633802,0.02310385],"category_scores_gemma":[0.02336529,0.0006508559,0.001907882,0.0007344731,0.002384366,0.004612844,0.002441546,0.04588065,0.01159567],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00390407,"about_ca_system_score_gemma":0.007104601,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008059978,"about_ca_topic_score_gemma":0.01331517,"domain_scores_codex":[0.9978951,0.0004812056,0.0003250766,0.0001975627,0.0005213478,0.0005795762],"domain_scores_gemma":[0.9922464,0.002661282,0.0006351323,0.0001806297,0.001058883,0.003217537],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006367459,0.0001404179,0.001916526,0.00004809074,0.00002293348,0.005157106,0.0001161428,0.00006298067,0.0001323561,0.002029427,0.979138,0.01117225],"study_design_scores_gemma":[0.0004302297,0.0002209043,0.004282776,0.001067422,0.000085974,0.01186397,0.001112717,0.000801276,0.0002041272,0.01701348,0.9627752,0.00014196],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0004760296,0.000665071,0.00005415857,0.9829539,0.01173863,0.000009180621,0.0000280838,0.00002367563,0.004051322],"genre_scores_gemma":[0.003203652,0.0009429154,0.000212464,0.9570152,0.02903843,0.00002636748,0.00003670603,0.00001840778,0.009505854],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.0633802,"threshold_uncertainty_score":0.07729012,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007719730762906128,"score_gpt":0.2474541201710379,"score_spread":0.2397343894081317,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}